WilmerHale Recognized by ChIPs With Inaugural Honor Roll Award for Efforts and Progress in Gender Equality

WilmerHale Recognized by ChIPs With Inaugural Honor Roll Award for Efforts and Progress in Gender Equality

WilmerHale is honored to be the recipient of the inaugural Honor Roll Award given by ChIPs at its annual Women in Tech, Law, and Policy Global Summit held October 17-19 in Washington, DC.

 LMG Life Sciences 2017 Honors WilmerHale With Top Rankings

LMG Life Sciences 2017 Honors WilmerHale With Top Rankings

LMG Life Sciences has recognized WilmerHale among the nation's leading life sciences law firms in its 2017 rankings, citing the firm's Life Sciences Practice as “renowned for its range and multidisciplinary teams that counsel clients in technology, pharmaceutical and medical device companies as well as investment banks and venture capitalists.”

WilmerHale Reps Apellis Pharmaceuticals in Initial Public Offering

WilmerHale Reps Apellis Pharmaceuticals in Initial Public Offering

Apellis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to treat disease through the inhibition of the complement system, announced the closing of its initial public offering.